Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy
Michaël R. Paillasse(Evotec (United States)), Pierre Fons(Evotec (United States))
Cited by 12
Related Papers
Targeted Identification of Sialoglycoproteins in Hypoxic Endothelial Cells and Validation in Zebrafish Reveal Roles for Proteins in Angiogenesis
|Journal of Biological Chemistry|2014|31